RelayPro Thoracic Stent-Graft System 28-N4-42-204-38URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of RelayPro Thoracic Stent-Graft System (127)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00843576151109), received between Aug 27, 2025 and Aug 27, 2025 — classified as 1 injury.
The most frequently reported specific device problem is “Device Endoleak” (1 report).
2 FDA recall records name this device's identifier, 2 still open.
1 other recall cover devices cleared under the same FDA submission (P200045); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Apr 22, 2026Class IOpen, Classified
Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system.
Z-2160-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
- Dec 20, 2022Class IIOpen, Classified
The product may be shorter than packaging indicates
Z-0998-2023 · Root cause: Labeling Change Control · Recall details · FDA record ↗
Most reported problems
Device problems
- Device Endoleak1
Patient problems
- Clinical Endoleak1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryAug 27, 2025Device Endoleak; Device Endoleak
"ON (B)(6) 2025 SUBJECT PRESENTED A CHRONIC DISSECTION; DETAILS OF THE PROCEDURE ARE STILL PENDING FROM THE SITE, HOWEVER, THE SITE DID REPORT A TYPE IIIA ENDOLEAK CONFIRMED BY CT AT INDEX PROCEDURE; SITE REPORTED THIS AS RELATED TO PROCEDURE AND DEVICE. PRIOR TO THE PROCEDURE THE SITE STATED THAT THE SUBJECT HAD AN ACUTE ON CHRONIC DISSECTION INVOLVING JUXTA SUPERIOR MESENTERIC ARTERY AORTA EXTENDING DISTALLY INTO RIGHT EXTERNAL ILIAC ARTERY AND INTO DISTAL SUPERIOR MESENTERIC ARTERY. FOLLOWING THE INDEX PROCEDURE, THE SITE REPORTED THAT THE PATIENT DEVELOPED A SMALL ILEUS ((B)(6) 2025 - REPORTED AS RELATED TO PROCEDURE), CT SCAN SHOWED AN INTRAMURAL HEMATOMA ALONG THE AORTIC ARCH ((B)(6) 2025 - REPORTED AS RELATED TO PROCEDURE), CT SCAN SHOWED A LEFT PLEURAL EFFUSION WITH COMPRESSIVE ATELECTASIS OF THE LINGULA AND LEFT LOWER LOBE ((B)(6) 2025 - REPORTED AS RELATED TO PROCEDURE), CT SCAN SHOWED A TREOPERITONEAL AND PELVIC HEMATOMA ((B)(6) 2025 - REPORTED AS RELATED TO PROCEDURE) AND SIGNIFICANT POST-OP PAIN ((B)(6) 2025 - REPORTED AS RELATED TO PROCEDURE)." PATIENT OUTCOME: "PENDING COMPLETION OF DATA ENTRY AND SITE WAS ASKED TO UPLOAD ALL IMAGING AND PROVIDE SOURCE DOCUMENTATION.
Patient problems: Clinical Endoleak
MAUDE report 22907454 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P200045. One submission often covers many models, so check the product and lot details in each record.
- Z-1383-2024 · Feb 22, 2024 · CompletedRELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 2
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page